Advanced Oncotherapy, the developer of a next generation proton therapy system for cancer treatment, has completed construction of its flagship site in London’s Harley Street.
The Howard de Walden Estate funded the £10m refurbishment project of the Grade II listed properties at 141 and 143 Harley Street, which will house the AIM-listed company’s first LIGHT system. The project will now move to the fit-out phase with the first patients expected to be treated at the centre towards the end of next year.
Advanced Oncotherapy CEO Nicolas Serandour said: ‘I am delighted that we have reached another important milestone in the pathway towards the first commercial installation of our technology. We are committed to creating a cost-effective proton therapy technology that will offer cancer patients better outcomes with lower treatment side-effects, and at the same time affordable enough to be made available to everyone who needs it. Once operational this centre is expected to be the world’s first-ever centrally located, lifesaving proton therapy centre, in what was originally a residential dwelling.’
Advanced Oncotherapy was granted a 50-year lease for the site in 2015 and Howard de Walden Estate agreed to bear the cost of redevelopment.
Simon Baynham, property director at Howard de Walden Estates, said: ‘We are delighted that our construction phase is now over and that the project is about to enter the next phase of fit-out. This transaction demonstrates that the Harley Street Medical Area continues to attract both the best technology and consultants available. The Harley Street Medical Area continues to provide the very best healthcare that doctors and science can provide in an increasingly global medical market.’